Pilianidis G, Papanastasiou G, Tikoudi P, Themistocleous A, Farmakis G, Dolianitis K. Can euglycemic diabetic ketoacidosis caused by SGLT2 inhibitors be avoided in COVID-19 and other acute infections?. EJCRIM 2024;11 doi:10.12890/2024_004282.